P630: SAFETY AND TREATMENT ADHERENCE WITH ACALABRUTINIB IN VERY OLD (≥80Y) AND/OR FRAIL PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - INTERIM SAFETY ANALYSIS OF THE ONGOING PHASE-II CLL-FRAIL TRIAL

Detalles Bibliográficos
Autores principales: Simon, Florian, Ligtvoet, Rudy, Noesslinger, Thomas, Bohn, Jan-Paul, Von Tresckow, Julia, Liersch, Rüdiger, Gaska, Tobias, Jentsch-Ullrich, Kathleen, Koenigsmann, Michael, Wolff, Thomas, Schwaner, Ingo, Wolf, Dominik, Schneider, Christof, Tausch, Eugen, Stilgenbauer, Stephan, Kreuzer, Karl-Anton, Robrecht, Sandra, Fink, Anna-Maria, Fürstenau, Moritz, Fischer, Kirsten, Goede, Valentin, Hallek, Michael, Eichhorst, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429528/
http://dx.doi.org/10.1097/01.HS9.0000969424.38447.63

Ejemplares similares

Ejemplares similares